Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Sunshine Lake Pharma Co., Ltd.)"
Count: 48
Selected: 0
NCT IDTitle
NCT04925674Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
NCT04925661HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
NCT05048368Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
NCT04992858Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
NCT04984512The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT04982913Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
NCT04865458A Phase I Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia(AML)
NCT04667429the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets
NCT04625361Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects
NCT04623814the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
NCT04591301The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
NCT04577703First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors
NCT04565171Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD
NCT04552808To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects
NCT04551261GLS4/RTV and TAF Drug-drug Interaction
NCT04546984Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
NCT04536532Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
NCT04512170Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects
NCT04422496The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT04324372Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
NCT04232514Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects
NCT04202952The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
NCT04201275The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
NCT04194242The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects
NCT04147208Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
NCT04131192Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT03943251The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects
NCT03903081The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects
NCT03888092Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
NCT03886688HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
NCT03876925A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
NCT03811678The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects
NCT03758287Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
NCT03673696The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects
NCT03663686The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
NCT03662568A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects
NCT03655873The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
NCT03638076The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
NCT03502902The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT03487107Phase 3 Study of Yimitasvir Phosphate Capsules
NCT03462173The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
NCT03458481Phase 2 Study of Yimitasvir Phosphate Capsules
NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
NCT03092102The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
NCT04601610KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma